3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
58
Carcinoma, Non-Small-Cell Lung
36
Urinary Bladder Neoplasms
33
Neoplasm Metastasis
20
Lung Neoplasms
20
Ovarian Neoplasms
19
Lymphoma, Large B-Cell, Diffuse
18
Cholangiocarcinoma
15
Neoplasms
14
Nasopharyngeal Carcinoma
14
Biliary Tract Neoplasms
14
Triple Negative Breast Neoplasms
13
Colorectal Neoplasms
12
Breast Neoplasms
12
Carcinoma, Transitional Cell
11
Non-Muscle Invasive Bladder Neoplasms
10
Fallopian Tube Neoplasms
10
Recurrence
9
Gallbladder Neoplasms
8
Sarcoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Bile Duct Neoplasms
6
Uterine Cervical Neoplasms
5
Osteosarcoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Hodgkin Disease
5
Endometrial Neoplasms
5
Melanoma
4
Gastrointestinal Neoplasms
4
Interventions
Magnetic Resonance Spectroscopy
3
Steroids
2
Specimen Handling
2
Hormones
2
Cyclin-Dependent Kinase Inhibitor p18
2
Cyclin-Dependent Kinase Inhibitor p16
2
Biopsy
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
radium Ra 223 dichloride
1
pertuzumab
1
abemaciclib
1
X-Rays
1
Trastuzumab
1
Taxoids
1
Taxes
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Photons
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Mastectomy, Simple
1
Mastectomy, Segmental
1
High-Energy Shock Waves
1
Capecitabine
1
CT-P6
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage IV Breast Cancer AJCC v8
×
Gemcitabine
×
90 days
×
Clear all
No trials found.